Artificial intelligence is no longer just promising in cancer diagnostics — it is demonstrating, in peer-reviewed clinical studies, the ability to detect cancers earlier, more accurately, and from more challenging tissue presentations than human experts alone. Two major studies published in April and May 2026 have pushed the boundaries of what AI-assisted cancer detection can accomplish and offer a glimpse at how the field of oncology may be transformed within the next decade.
The first, published in Nature Cancer by a team at the Hong Kong University of Science and Technology, introduced PRET — a "plug-and-play" AI pathology system capable of recognizing 18 distinct cancer types from just a handful of tissue slides, without requiring any additional training specific to the institution or patient population where it is deployed. The second, published in Gut by Mayo Clinic researchers, demonstrated an AI system that detected pancreatic cancer from routine CT scans up to three years before clinical diagnosis — nearly doubling the detection rate achieved by specialist radiologists reviewing the same scans without AI assistance.
